MedPath

Repaired Tetralogy of Fallot Italian Registry

Recruiting
Conditions
Cardiac Event
Cardiac Death, Sudden
Tetralogy of Fallot
Cardiac Arrhythmia
Interventions
Diagnostic Test: Cardiac magnetic resonance imaging
Registration Number
NCT05288894
Lead Sponsor
Azienda Ospedaliero, Universitaria Ospedali Riuniti
Brief Summary

The CMR/CT WG of the Italian pediatric cardiology society set up a multi-center observational clinical database of repaired-TOF evaluated. This registry will enroll prospectively patients evaluated by CMR for clinical indication in most of the CHD Italian centers. Data collection will include surgical history, clinical data, imaging data, and also adverse cardiac events for a period of 6 years.

Detailed Description

This is an observational prospective registry that will enroll patients presenting with repaired Tetralogy of Fallot (TOF) undergoing a cardiac magnetic resonance (CMR) imaging study in our recruiting CMR-Laboratories.

CMR imaging studies will include the evaluation of biventricular volumes and function, atrial volumes and function, and the Late Gadolinium Enhancement (LGE), along with the evaluation of the anatomy and flow of the main pulmonary arteries and branches. We will also assess the aortic valve for regurgitation and measurement of the aortic size.

At follow-up, any interventional or surgical procedures performed and symptoms or any major (Death) and cardiac (cardiac-related hospitalization) events will be collected.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
150
Inclusion Criteria
  • Patients with Repaired - TOF
Exclusion Criteria
  • Age < 10 years
  • Other associated complex pathology such as MAPCAs, Atrioventricular canal, Ebstein
  • Incomplete CMR exam

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Repaired Tetralogy of FallotCardiac magnetic resonance imagingA patient affected by Tetralogy of Fallot (right ventricle outflow obstruction, right ventricle hypertrophy, ventricular septal defect, aortic overriding of the ventricular defect) that already underwent cardiac surgery for the correction.
Primary Outcome Measures
NameTimeMethod
Cardiac death6 years

Number of Participants with cardiac-releted death

Secondary Outcome Measures
NameTimeMethod
Hospitalizations6 years

Rate of cardiac-related hospitalizations due to cardiac arrhythmias or cardaio failure

Trial Locations

Locations (1)

CCPC

🇮🇹

Ancona, Marche, Italy

© Copyright 2025. All Rights Reserved by MedPath